SIRT3 and Duchenne muscular dystrophy: In future, carefully designed pulmonary endothelial permeability experiments might be able to reveal alveolar leakage phenotype, and its subsequent mitigation by Sirt3 inhibition in a suitable DMD mouse disease model.